No Detail Found!

Molecular characterization of mbl in uropathogenic E. coli isolated from patients of Tertiary Care Hospital

Author(s)
Sabahat Asghar Department of Pathology, Ayub Medical College,Abbottabad-,Pakistan
Abid Ali Khuwaj Department of Pathology, Ayub Medical College,Abbottabad-,Pakistan
Muhammad Arfat COMSATS Islamabad-,,Pakistan
Noreen Taj Department of Pathology, Ayub Medical College,Abbottabad-,Pakistan
Maria Akhtar Department of Pathology, Ayub Medical College,Abbottabad-,Pakistan
Ihsan Ullah Khyber Medical University Peshawar-,,Pakistan
Abstract
Background: Antibiotic resistance is on an increasing trend, particularly in gram-negative bacteria. The production of metallo ß-lactamase (MBL) puts the health sector at great risk as it further limits the treatment option for MDR strain. The current study aims to determine the prevalence, antibacterial sensitivity pattern, and molecular characterization of MBL in Uropathogenic E. coli from clinical samples of hospitalized patients in Khyber Pakhtunkhwa. Methods: From tertiary care hospitals in Peshawar, 250 Urine samples were collected from indoor hospitalized patients. Gold standard microbiological methods were used to identify UPEC from these clinical samples.For that,urine samples was inoculated onto Cysteine Lactose Electrolyte. Deficient (CLED) agar plate, and MacConkey Agar.Positive growth of E. coli identified through Gram staining, colony morphology, Biochemical Tests and E.coli 16srRNA gene amplification .Antibiotic sensitivity was determined by the disc diffusion method on Muller Hinton agar. For the detection of MBL production double disc synergy, and a combination disc test of the antibiotics were used. Furthermore, multiplex PCR was used for the molecular characterization of the MBL (blaIMP, blaVIM, and blaNDM) genes. Results: Of the 250 samples, only 110 samples were confirmed as Uropathogenic E. coli based on colonial morphology, biochemical testing, and molecular level by targeting the 16SrDNA. Female was found more susceptible to UTI compared to male. High prevalence was found in the age group 45-65 years. UPEC was found highly resistance to Ciprofloxacin (90%), followed by Cefotaxime and Ceftriaxone (86%), Ceftazidime and Augmentin (81%), Tazobactam (61%). while the lowest resistance was reported against Meropenum (20%) Imipenem (18%) and Amikacin (37%). PCR-based confirmed prevalence of MBL encoding genes was blaNDM (42%), blaVIM (32%), and blaIMP (26%). Conclusion: The study proposed a higher prevalence of urinary tract infections (UTIs) in females aged group 54-65 years compared to males. An analysis of antibiotic sensitivity revealed Imipenem and Meropenem to be the most effective antimicrobial agents, while Ciprofloxacin, Cefotaxime and Amoxicillin were found to be the less effective. UPEC were found highly resistance to Ciprofloxacin 91%, and ceftazidime 86%, while comparatively less resistance to meropenem, and imipenem,20% and 18% respectively. Genotype BlaNDM of the MBL is highly prevalent (42%) among UPEC.Furthermore, the presence of MBL genes was detected in over 19% of UPEC, and in different combinations.The upraise of the MBLs resistance in uropathogenic E. coli is an alarming sign for clinicians to decide on treatment options for complicated UTIs.
Publication Details
Page(s) 778-782
Published Journal: Journal of Ayub Medical College, Volume: 36, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
Escherichia coli, Urinary tract infection, Extended Spectrum Beta Lactamase (ESBL), Metallo beta lactamase (MBL)
References
Flores-Mireles AL,Walker JN,Caparon M,Hultgren SJ .2015 .Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol, 13(5) : 269-84.
Luna-Pineda V,Ochoa S,Cruz Córdova A,Cázares V,Vélez F,Hernández-Castro R .2018 .Urinary tract infections, immunity. Bol Méd Hosp Infant Méx, 75(2) : 67-78.
Morris S,Cerceo E .2020 .management of multi-drug resistant gram-negative bacterial infections in the hospitalized setting. Antibiotics, 9(4) : 196.
Aurilio C,Sansone P,Barbarisi M,Pota V,Giaccari LG,Coppolino F .2022 .Mechanisms of action of carbapenem resistance. Antibiotics, 11(3) : 421.
Yong D,Toleman MA,Giske CG,Cho HS,Sundman K,Lee K .2009 .Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother, 53(12) : 5046-54.
Queenan AM,Bush K. .2007 .Carbapenemases: the versatile β- lactamases. Clin Microbiol Rev, 20(3) : 440-58.
Poirel L,Dortet L,Bernabeu S .2011 .Genetic features of bla NDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother, 55(11) : 5403-7.
Zangane Matin F,Rezatofighi SE,Roayaei Ardakani M,Akhoond MR,Mahmoodi F .2021 .Virulence characterization and clonal analysis of uropathogenic Escherichia coli metallobeta-lactamase-producing isolates. Ann Clin Microbiol Antimicrob, 20(1) : 50.
Aurilio C,Sansone P,Barbarisi M,Pota V,Giaccari LG,Coppolino F .2022 .Mechanisms of action of carbapenem resistance. Antibiotics, 11(3) : 421.
Oelschlaeger P,Mayo SL .2005 .Hydroxyl groups in the ββ sandwich of metallo-β-lactamases favor enzyme activity: a computational protein design study. J Mol Biol, 350(3) : 395-401.
Isenberg HD. Clinical,Microbiology Procedures Handbook HD. Clinical .2004 .. , : .
Gautam V,Singhal L,Arora S,Jha C .2013 .Reliability of KirbyBauer disk diffusion method for detecting carbapenem resistance in Acinetobacter baumannii-calcoaceticus complex isolates. Antimicrob Agents Chemother, 57(4) : 2003-4.
.2018 .cited 2024 May]. CLSI, : .
Poirel L,Walsh TR,Cuvillier V,Nordmann P .2011 .Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis, 70(1) : 119-23.
Zhu C,Wang DQ,Zi H,Huang Q,Gu JM,Li LY .2021 .Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Mil Med Res, 8(1) : 64.
Aurilio C,Sansone P,Barbarisi M,Pota V,Giaccari LG,Coppolino F .2022 .Mechanisms of action of carbapenem resistance. Antibiotics, 11(3) : 421.
Sadeghi A,Halaji M,Fayyazi A,Havaei SA .2020 .Characterization of plasmid-mediated quinolone resistance and serogroup distributions of uropathogenic Escherichia coli among Iranian kidney transplant patients. BioMed Res Int, : 2850183.
Nwokolo CJ,Ugwu MC,Ejikeugwu CP,Iroha IR,Esimone CO .2022 .Incidence and antibiotic susceptibility profile of uropathogenic Escherichia coli positive for extended spectrum β-lactamase among HIV/AIDS patients in Awka metropolis. Nigeria. Iranian J Microbiol, 14(3) : 334-40.
Skrzat-Klapaczyńska A,Matłosz B,Bednarska A,Paciorek M,Firląg-Burkacka E,Horban A .2018 .Factors associated with urinary tract infections among HIV-1 infected patients. PLoS One, 13(1) : e0190564.
Tüzün T,Kutlu SS,Kutlu M,Kaleli İ .2019 .Risk factors for community-onset urinary tract infections caused by extended-spectrum ß-lactamase-producing Escherichia coli. Turkish J Med Sci, 49(4) : 1206-11.
Ehsan B,Haque A,Qasim M,Ali A,Sarwar Y. .2023 .High prevalence of extensively drug resistant and extended spectrum beta lactamases (ESBLs) producing uropathogenic Escherichia coli isolated from Faisalabad, Pakistan. World J Microbiol Biotechnol, 39(5) : 132.
Ahmed N,Khalid H,Mushtaq M,Basha S,Rabaan AA,Garout M .2022 .The molecular characterization of virulence determinants and antibiotic resistance patterns in human bacterial uropathogens. Antibiotics, 11(4) : 516.
Kar B,Sharma M,Peter A,Chetia P,Neog B,Borah A .2021 .Prevalence and molecular characterization of β-lactamase producers and fluoroquinolone resistant clinical isolates from North East India. J Infect Public Health, 14(5) : 628-37.
Contreras-Alvarado LM,Zavala-Vega S,Cruz-Córdova A,Reyes-Grajeda JP,Escalona-Venegas G,Flores V .2021 .Molecular epidemiology of multidrug-resistant uropathogenic Escherichia coli O25b strains associated with complicated urinary tract infection in children. Microorganisms, 9(11) : 2299.
Cai Y,Chen C,Zhao M,Yu X,Lan K,Liao K .2019 .High prevalence of metallo-β-lactamase-producing Enterobacter cloacae from three tertiary hospitals in China. Front Microbiol, 10 : 1610.
0

Citations

0

Downloads

66

Views